Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126029821 | 12602982 | 1 | I | 20160720 | 20160728 | 20160728 | EXP | US-PFIZER INC-2016355063 | PFIZER | WOODLEY, D. W.. THE TREATMENT OF SEVERE STAPHYLOCOCCAL INFECTIONS WITH VANCOMYCIN. ANNALS OF INTERNAL MEDICINE. 1961;55:235-249 | 28.00 | YR | M | Y | 0.00000 | 20160728 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126029821 | 12602982 | 1 | PS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1 G, UNK, (1 G IN 500 ML Q.12 HR) | Y | 62911 | 1 | G | BID | ||||||
| 126029821 | 12602982 | 2 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Y | 62911 | |||||||||||
| 126029821 | 12602982 | 3 | SS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Y | 62911 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126029821 | 12602982 | 1 | Osteomyelitis |
| 126029821 | 12602982 | 2 | Sepsis |
| 126029821 | 12602982 | 3 | Paraplegia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126029821 | 12602982 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126029821 | 12602982 | Deafness neurosensory | |
| 126029821 | 12602982 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |